ACNT ASCENT INDUSTRIES CO.
Chemicals & Allied Products · Nasdaq · SEC CIK 95953 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY22.4%
TTM net income YoY-207.7%
TTM EPS YoY-211.1%
Revenue 3-yr CAGR-23.9%
Net income 3-yr CAGR—
Margins
Gross margin20.8%
Operating margin-2.7%
Net margin-1.0%
FCF margin-8.7%
EBITDA margin-1.3%
Returns
ROE-1.1%
ROA-0.8%
ROIC (approx.)-4.8%
Asset turnover0.80x
Leverage & solvency
Liabilities / assets24.6%
Debt / equity0.00x
Current ratio4.50x
Interest coverage—
Cash quality & payout
Operating cash flow / net income5.48x
Accruals ratio3.7%
Payout ratio—
Capex / revenue3.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $74.94M | $80.76M | $193.18M | $261.99M | $334.71M |
| Cost of revenue | $57.73M | $70.07M | $191.65M | $218.71M | $273.95M |
| Gross profit | $17.21M | $10.69M | $1.53M | $43.29M | $60.77M |
| R&D expense | $71,000 | $0 | — | — | — |
| SG&A expense | $22.96M | $19.86M | $26.71M | $27.64M | $30.14M |
| Operating income | -$7.03M | -$10.80M | -$37.43M | $14.54M | $27.35M |
| Interest expense | — | $418,000 | $4.24M | $2.74M | $1.49M |
| Pretax income | -$5.56M | -$10.77M | -$41.08M | $12.01M | $25.50M |
| Income tax | $22,000 | $1.81M | -$6.92M | -$5.57M | $5.25M |
| Net income | $867,000 | -$13.60M | -$26.63M | $22.07M | $20.25M |
| EBITDA | -$5.89M | -$9.76M | -$31.27M | $20.96M | $37.69M |
| EPS (basic) | 0.09 | -1.35 | -2.63 | 2.16 | 2.17 |
| EPS (diluted) | 0.09 | -1.35 | -2.63 | 2.12 | 2.14 |
| Dividends declared per share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 9.64M | 10.11M | 10.14M | 10.41M | 9.46M |
| Balance sheet | |||||
| Cash & equivalents | $57.61M | $16.11M | $1.84M | $1.44M | $2.02M |
| Receivables | $10.04M | $12.23M | $15.10M | $33.20M | $33.42M |
| Inventory | $8.74M | $5.73M | $52.31M | $67.67M | $103.25M |
| Current assets | $83.02M | $83.07M | $89.41M | $170.38M | $159.98M |
| PP&E, net | $15.76M | $17.59M | $29.75M | $35.53M | $43.72M |
| Goodwill | $0 | $0 | $0 | $11.39M | $12.64M |
| Intangibles | $2.83M | $3.44M | $8.50M | $10.00M | $14.38M |
| Total assets | $111.94M | $147.25M | $163.29M | $269.04M | $266.00M |
| Current liabilities | $12.36M | $22.35M | $24.79M | $33.48M | $50.49M |
| Short-term debt | — | — | $0 | $2.46M | $2.46M |
| Long-term debt | — | $0 | $0 | $69.08M | $67.93M |
| Total debt | — | $0 | $0 | $71.55M | $70.39M |
| Total liabilities | $24.95M | $53.70M | $55.88M | $134.78M | $154.41M |
| Shareholders' equity | $86.99M | $93.55M | $107.41M | $134.26M | $111.59M |
| Net debt | — | -$16.11M | -$1.84M | $70.11M | $68.38M |
| Shares outstanding | 9.40M | 10.07M | 10.07M | 10.09M | 10.16M |
| Cash flow statement | |||||
| Operating cash flow | -$519,000 | $14.68M | $23.08M | $5.58M | $19.05M |
| Capital expenditure | $1.54M | $1.12M | $2.88M | $3.39M | $1.50M |
| Free cash flow | -$2.06M | $13.56M | $20.19M | $2.18M | $17.56M |
| Investing cash flow | $50.98M | $905,000 | $50.50M | -$4.97M | -$32.66M |
| Financing cash flow | -$8.96M | -$1.33M | -$73.17M | -$1.18M | $15.39M |
| Depreciation & amortization | $1.13M | $1.04M | $6.16M | $6.42M | $10.34M |
| Stock-based compensation | $1.30M | $760,000 | $1.02M | $1.35M | $799,000 |
| Share buybacks | $9.14M | $1.04M | $1.29M | $1.34M | $0 |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.